Depp, Colin A.
Bashem, Jesse
Moore, Raeanne C.
Holden, Jason L.
Mikhael, Tanya
Swendsen, Joel
Harvey, Philip D.
Granholm, Eric L.
Article History
Received: 14 March 2019
Accepted: 23 September 2019
First Online: 8 November 2019
Competing interests
: Dr. Harvey has received consulting fees or travel reimbursements from Allergan, Alkermes, Akili, Biogen, Boehringer Ingelheim, Forum Pharma, Genentech (Roche Pharma), Intra-Cellular Therapies, Jazz Pharma, Lundbeck Pharma, Minerva Pharma, Otsuka America (Otsuka Digital Health), Sanofi Pharma, Sunovion Pharma, Takeda Pharma, and Teva. He receives royalties from the Brief Assessment of Cognition in Schizophrenia and the MATRICS Consensus Battery. He is chief scientific officer of i-Function, Inc. He has a research grant from Takeda and from the Stanley Medical Research Foundation. Dr. Granholm has received consulting fees from Otsuka Pharmaceuticals. The remaining authors declare no competing interests.